NASDAQ:MREO

Mereo Biopharma Group Stock News

Healthcare > Biotechnology

Buy MREO

*Your capital is at risk

$0.334

-0.0052 (-1.53%)

At Close: Jun 03, 2026

MREO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Mereo BioPharma Group plc

02:01am, Friday, 06'th Feb 2026

SAN DIEGO, Feb. 6, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASD

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

08:39pm, Thursday, 05'th Feb 2026

LOS ANGELES--(BUSINESS WIRE)---- $MREO--MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm.

MEREO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Mereo BioPharma Group plc and Encourages Investors to Contact the Firm

04:54pm, Thursday, 05'th Feb 2026

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Mereo (MREO) To Contact Him Directly To Discuss Their Options

Berger Montague PC Investigating Claims on Behalf of Investors in Mereo BioPharma Group PLC (MREO) After Class Action Filing

03:52pm, Thursday, 05'th Feb 2026

Philadelphia, Pennsylvania--(Newsfile Corp. - February 5, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Mereo BioPharma Group pl

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Mereo BioPharma

03:50pm, Thursday, 05'th Feb 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Mereo BioPharma To Contact Him Directly To Discuss Their Options

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Mereo BioPharma Group plc (MREO)

11:53am, Thursday, 05'th Feb 2026

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of N

Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders to Contact the Firm for Information About Their Rights

11:32am, Thursday, 05'th Feb 2026

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of American Depositary Shares (“ADS”) of Mereo BioPharma Grou

INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Mereo BioPharma Group plc (MREO) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm

10:37am, Thursday, 05'th Feb 2026

ATLANTA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Mereo BioPharma Group plc (“Mereo” or the “Company”) (NASDAQ: MREO). The lawsuit alleges th

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Mereo BioPharma Group plc American Depositary Shares and Sets a Lead Plaintiff Deadline of April 6, 2026

08:31pm, Wednesday, 04'th Feb 2026

NEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired American Depositary Shares

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit

08:27pm, Wednesday, 04'th Feb 2026

SAN DIEGO--(BUSINESS WIRE)---- $MREO #Biopharmaceutical--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma G

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by